NCLAT: IRP Has Authority to Take Possession of Assets Owned by Corporate Debtor  ||  NCLAT: NCLT Can Direct Forwarding a Copy of its Order to Relevant Statutory Authorities  ||  Delhi HC: Centre to Expedite Process of Accessibility Features in OTT platforms for PwDs  ||  Delhi HC: Once Worker Provides Testimony Under Oath ‘Burden of Proof’ Shifts on Employer  ||  SC: There Cannot be Discrimination in Matter of Payment of Pension to Retired Judges  ||  SC: India is Not a Dharamshala that Can Entertain Foreign Nationals from All Over  ||  SC: Can Quash Domestic Violence Act Complaints Under Section 482 of CrPC  ||  Supreme Court: Can’t Use Statement of One Accused against Another  ||  SC: Inclusion of Name in Draft NRC Cannot Annul Foreigners Tribunal’s Declaration as Non-Citizen  ||  Supreme Court: Minimum Practice of 3 Years Mandatory to Enter Judicial Service    

Delhi HC Directs Centre to File Report on Production Capacity of Amphotericin B Drug - (21 May 2021)

CIVIL

Delhi High Court has directed the Centre to file status report indicating the present production capacity of the Amphotericin B drug, along with the enhanced production capacity of producers who have been licensed to produce the aforesaid drug, observing that doubling the present production capacity of the drug used to treat Black Fungus may not be sufficient.

Tags : DELHI HIGH COURT   PRODUCTION OF AMPHOTERICIN B DRUG  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved